<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36168806</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2046-2441</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Open biology</Title><ISOAbbreviation>Open Biol</ISOAbbreviation></Journal><ArticleTitle>Familial ALS-associated <i>SFPQ</i> variants promote the formation of SFPQ cytoplasmic aggregates in primary neurons.</ArticleTitle><Pagination><StartPage>220187</StartPage><MedlinePgn>220187</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">220187</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1098/rsob.220187</ELocationID><Abstract><AbstractText>Splicing factor proline- and glutamine-rich (SFPQ) is a nuclear RNA-binding protein that is involved in a wide range of physiological processes including neuronal development and homeostasis. However, the mislocalization and cytoplasmic aggregation of SFPQ are associated with the pathophysiology of amyotrophic lateral sclerosis (ALS). We have previously reported that zinc mediates SFPQ polymerization and promotes the formation of cytoplasmic aggregates in neurons. Here we characterize two familial ALS (fALS)-associated <i>SFPQ</i> variants, which cause amino acid substitutions in the proximity of the SFPQ zinc-coordinating centre (N533H and L534I). Both mutants display increased zinc-binding affinities, which can be explained by the presence of a second zinc-binding site revealed by the 1.83 &#xc5; crystal structure of the human SFPQ L534I mutant. Overexpression of these fALS-associated mutants significantly increases the number of SFPQ cytoplasmic aggregates in primary neurons. Although they do not affect the density of dendritic spines, the presence of SFPQ cytoplasmic aggregates causes a marked reduction in the levels of the GluA1, but not the GluA2 subunit of AMPA-type glutamate receptors on the neuronal surface. Taken together, our data demonstrate that fALS-associated mutations enhance the propensity of SFPQ to bind zinc and form aggregates, leading to the dysregulation of AMPA receptor subunit composition, which may contribute to neuronal dysfunction in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Widagdo</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9667-9203</Identifier><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udagedara</LastName><ForeName>Saumya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhembre</LastName><ForeName>Nishita</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3252-8929</Identifier><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Jing Zhi Anson</ForeName><Initials>JZA</Initials><Identifier Source="ORCID">0000-0002-6537-1166</Identifier><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neureiter</LastName><ForeName>Lara</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0638-8774</Identifier><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4535-4489</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anggono</LastName><ForeName>Victor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4062-4884</Identifier><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Mihwa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3006-2483</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.c.6198497</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Open Biol</MedlineTA><NlmUniqueID>101580419</NlmUniqueID><ISSNLinking>2046-2441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072670">PTB-Associated Splicing Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072260">RNA Splicing Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018091">Receptors, AMPA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017470">Receptors, Glutamate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0RH81L854J</RegistryNumber><NameOfSubstance UI="D005973">Glutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>77521-29-0</RegistryNumber><NameOfSubstance UI="D018350">alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9DLQ4CIU6V</RegistryNumber><NameOfSubstance UI="D011392">Proline</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072670" MajorTopicYN="N">PTB-Associated Splicing Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011392" MajorTopicYN="N">Proline</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072260" MajorTopicYN="N">RNA Splicing Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018091" MajorTopicYN="N">Receptors, AMPA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017470" MajorTopicYN="N">Receptors, Glutamate</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018350" MajorTopicYN="N">alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DBHS proteins</Keyword><Keyword MajorTopicYN="N">RNA binding proteins</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">glutamate receptors</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">zinc</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>3</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36168806</ArticleId><ArticleId IdType="pmc">PMC9516340</ArticleId><ArticleId IdType="doi">10.1098/rsob.220187</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conlon EG, Manley JL. 2017. RNA-binding proteins in neurodegeneration: mechanisms in aggregate. Genes Dev. 31, 1509-1528. (10.1101/gad.304055.117)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.304055.117</ArticleId><ArticleId IdType="pmc">PMC5630017</ArticleId><ArticleId IdType="pubmed">28912172</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbacher JK, Tabet R, Yeo GW, Lagier-Tourenne C. 2019. Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron 102, 294-320. (10.1016/j.neuron.2019.03.014)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.03.014</ArticleId><ArticleId IdType="pmc">PMC6545120</ArticleId><ArticleId IdType="pubmed">30998900</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin FE, Wilce JA. 2019. TDP-43 and FUS-structural insights into RNA recognition and self-association. Curr. Opin. Struct. Biol. 59, 134-142. (10.1016/j.sbi.2019.07.012)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.07.012</ArticleId><ArticleId IdType="pubmed">31479821</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R, et al. 2018. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 9, 1-15. (10.1038/s41467-018-04373-8)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04373-8</ArticleId><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas-Jinu S, et al. 2017. Non-nuclear pool of splicing factor SFPQ regulates axonal transcripts required for normal motor development. Neuron 94, 322-336. (10.1016/j.neuron.2017.03.026)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.026</ArticleId><ArticleId IdType="pmc">PMC5405110</ArticleId><ArticleId IdType="pubmed">28392072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan AL, et al. 2021. Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 47, 990-1003. (10.1111/nan.12749)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12749</ArticleId><ArticleId IdType="pubmed">34288034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim YW, James D, Huang J, Lee M. 2020. The emerging role of the RNA-binding protein SFPQ in neuronal function and neurodegeneration. Int. J. Mol. Sci. 21, 7151. (10.3390/ijms21197151)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197151</ArticleId><ArticleId IdType="pmc">PMC7582472</ArticleId><ArticleId IdType="pubmed">32998269</ArticleId></ArticleIdList></Reference><Reference><Citation>Knott GJ, Bond CS, Fox AH. 2016. The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold. Nucleic Acids Res. 44, 3989-4004. (10.1093/nar/gkw271)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw271</ArticleId><ArticleId IdType="pmc">PMC4872119</ArticleId><ArticleId IdType="pubmed">27084935</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery LA, Rubin J, Sive H. 2007. Whitesnake/sfpq is required for cell survival and neuronal development in the zebrafish. Dev. Dyn. 236, 1347-1357. (10.1002/dvdy.21132)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.21132</ArticleId><ArticleId IdType="pubmed">17393485</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosker KE, Fenstermacher SJ, Pazyra-Murphy MF, Elliott HL, Segal RA. 2016. The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability. Nat. Neurosci. 19, 690-696. (10.1038/nn.4280)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4280</ArticleId><ArticleId IdType="pmc">PMC5505173</ArticleId><ArticleId IdType="pubmed">27019013</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi A, et al. 2018. Loss of Sfpq causes long-gene transcriptopathy in the brain. Cell Rep. 23, 1326-1341. (10.1016/j.celrep.2018.03.141)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.141</ArticleId><ArticleId IdType="pubmed">29719248</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Ringuet M, Whitten AE, Caria S, Lim YW, Badhan R, Anggono V, Lee M. 2020. Structural basis of the zinc-induced cytoplasmic aggregation of the RNA-binding protein SFPQ. Nucleic Acids Res. 48, 3356-3365. (10.1093/nar/gkaa076)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa076</ArticleId><ArticleId IdType="pmc">PMC7102971</ArticleId><ArticleId IdType="pubmed">32034402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewage TW, Caria S, Lee M. 2019. A new crystal structure and small-angle X-ray scattering analysis of the homodimer of human SFPQ. Acta Crystallogr. F Struct. Biol. Commun. 75, 439-449. (10.1107/S2053230X19006599)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2053230X19006599</ArticleId><ArticleId IdType="pmc">PMC6572092</ArticleId><ArticleId IdType="pubmed">31204691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, et al. 2015. The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation. Nucleic Acids Res. 43, 3826-3840. (10.1093/nar/gkv156)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv156</ArticleId><ArticleId IdType="pmc">PMC4402515</ArticleId><ArticleId IdType="pubmed">25765647</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Casas Garcia GP, Perugini MA, Fox AH, Bond CS, Lee M. 2018. Crystal structure of a SFPQ/PSPC1 heterodimer provides insights into preferential heterodimerization of human DBHS family proteins. J. Biol. Chem. 293, 6593-6602. (10.1074/jbc.RA117.001451)</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.001451</ArticleId><ArticleId IdType="pmc">PMC5925804</ArticleId><ArticleId IdType="pubmed">29530979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai Y, Dohmae N, Hirokawa N. 2004. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43, 513-525. (10.1016/j.neuron.2004.07.022)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.07.022</ArticleId><ArticleId IdType="pubmed">15312650</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa MT, Sakamoto H, Inoue K. 2015. Interaction and colocalization of HERMES/RBPMS with NonO, PSF, and G3BP1 in neuronal cytoplasmic RNP granules in mouse retinal line cells. Genes Cells 20, 257-266. (10.1111/gtc.12224)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12224</ArticleId><ArticleId IdType="pubmed">25651939</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda Y, et al. 2021. Binding and transport of SFPQ-RNA granules by KIF5A/KLC1 motors promotes axon survival. J. Cell Biol. 220, e202005051. (10.1083/jcb.202005051)</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202005051</ArticleId><ArticleId IdType="pmc">PMC7721913</ArticleId><ArticleId IdType="pubmed">33284322</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SS, Botelho HM, Gomes CM. 2012. Metal ions as modulators of protein conformation and misfolding in neurodegeneration. Coord. Chem. Rev. 256, 2253-2270. (10.1016/j.ccr.2012.04.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2012.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederickson CJ, Koh JY, Bush AI. 2005. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 6, 449-462. (10.1038/nrn1671)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1671</ArticleId><ArticleId IdType="pubmed">15891778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozumi I, Yamada M, Uchida Y, Ozawa K, Takahashi H, Inuzuka T. 2008. The expression of metallothioneins is diminished in the spinal cords of patients with sporadic ALS. Amyotroph. Lateral Scler. 9, 294-298. (10.1080/17482960801934312)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801934312</ArticleId><ArticleId IdType="pubmed">18608104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozumi I, et al. 2011. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 303, 95-99. (10.1016/j.jns.2011.01.003)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.01.003</ArticleId><ArticleId IdType="pubmed">21292280</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanias GD, Kapaki E. 1997. Trace elements, age, and sex in amyotrophic lateral sclerosis disease. Biol. Trace Elem. Res. 56, 187-201. (10.1007/BF02785392)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02785392</ArticleId><ArticleId IdType="pubmed">9164664</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn MD, et al. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr. D67, 235-242. (10.1107/S0907444910045749)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910045749</ArticleId><ArticleId IdType="pmc">PMC3069738</ArticleId><ArticleId IdType="pubmed">21460441</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D66, 12-21. (10.1107/S0907444909042073)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909042073</ArticleId><ArticleId IdType="pmc">PMC2803126</ArticleId><ArticleId IdType="pubmed">20057044</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ. 2018. Driven to decay: excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain Res Bull. 140, 318-333. (10.1016/j.brainresbull.2018.05.023)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.023</ArticleId><ArticleId IdType="pubmed">29870780</ArticleId></ArticleIdList></Reference><Reference><Citation>Anggono V, Huganir RL. 2012. Regulation of AMPA receptor trafficking and synaptic plasticity. Curr. Opin. Neurobiol. 22, 461-469. (10.1016/j.conb.2011.12.006)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2011.12.006</ArticleId><ArticleId IdType="pmc">PMC3392447</ArticleId><ArticleId IdType="pubmed">22217700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y, Dramiga J, Schutz U, Kril JJ, Ittner LM, Schroder H, Gotz J. 2012. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease. PLoS ONE 7, e35678. (10.1371/journal.pone.0035678)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035678</ArticleId><ArticleId IdType="pmc">PMC3338448</ArticleId><ArticleId IdType="pubmed">22558197</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. 2006. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762, 1068-1082. (10.1016/j.bbadis.2006.05.002)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Ozdinler PH, Kiernan MC, Vucic S. 2016. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat. Rev. Neurol. 12, 651-661. (10.1038/nrneurol.2016.140)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley EE, Pitman KA, Dawkins E, Young KM, Clark RM, Jiang TC, Turner BJ, Dickson TC, Blizzard CA. 2017. Synapse dysfunction of layer V pyramidal neurons precedes neurodegeneration in a mouse model of TDP-43 proteinopathies. Cereb Cortex 27, 3630-3647. (10.1093/cercor/bhw185)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhw185</ArticleId><ArticleId IdType="pubmed">27496536</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Handley E, Brizuela M, Dawkins E, Lewis KEA, Clark RM, Dickson TC, Blizzard CA. 2019. Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function. Dis. Model Mech. 12, dmm038109. (10.1242/dmm.038109)</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.038109</ArticleId><ArticleId IdType="pmc">PMC6550035</ArticleId><ArticleId IdType="pubmed">31036551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Mu EW, Noakes PG, Lavidis NA, Bellingham MC. 2016. Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 4, 77. (10.1186/s40478-016-0347-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0347-y</ArticleId><ArticleId IdType="pmc">PMC4973034</ArticleId><ArticleId IdType="pubmed">27488828</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa T, et al. 2015. FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization. Nat. Commun. 6, 7098. (10.1038/ncomms8098)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8098</ArticleId><ArticleId IdType="pmc">PMC4479014</ArticleId><ArticleId IdType="pubmed">25968143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S, et al. 2017. Altered tau isoform ratio caused by loss of FUS and SFPQ function leads to FTLD-like phenotypes. Cell Rep. 18, 1118-1131. (10.1016/j.celrep.2017.01.013)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.01.013</ArticleId><ArticleId IdType="pubmed">28147269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S, et al. 2020. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases. Brain 143, 2398-2405. (10.1093/brain/awaa196)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa196</ArticleId><ArticleId IdType="pubmed">34462374</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory JM, Livesey MR, McDade K, Selvaraj BT, Barton SK, Chandran S, Smith C. 2020. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain. J. Pathol. 250, 67-78. (10.1002/path.5351)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5351</ArticleId><ArticleId IdType="pmc">PMC6973025</ArticleId><ArticleId IdType="pubmed">31579943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, Aizawa H, Jeong SY, Kanazawa I. 2003. Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. J. Neurochem. 85, 680-689. (10.1046/j.1471-4159.2003.01703.x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01703.x</ArticleId><ArticleId IdType="pubmed">12694394</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer MS, Reale LA, Lewis KE, Walker AK, Dickson TC, Woodhouse A, Blizzard CA. 2021. Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex. J. Neurochem. 157, 1300-1315. (10.1111/jnc.15214)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15214</ArticleId><ArticleId IdType="pubmed">33064315</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj BT, et al. 2018. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca(2+)-permeable AMPA receptor-mediated excitotoxicity. Nat. Commun. 9, 347. (10.1038/s41467-017-02729-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright AL, et al. 2021. Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 54, 6237-6255. (10.1111/ejn.15422)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15422</ArticleId><ArticleId IdType="pubmed">34390052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Kwak S. 2005. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons? Amyotroph. Lateral Scler. Other Motor Neuron Disord. 6, 131-144. (10.1080/14660820510037872)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510037872</ArticleId><ArticleId IdType="pubmed">16183555</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters JJ, Leitz J, Oses-Prieto JA, Burlingame AL, Brunger AT. 2021. Molecular characterization of AMPA-receptor-containing vesicles. Front. Mol. Neurosci. 14, 754631. (10.3389/fnmol.2021.754631)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.754631</ArticleId><ArticleId IdType="pmc">PMC8554035</ArticleId><ArticleId IdType="pubmed">34720876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan R, Lai KO. 2022. Understanding how kinesin motor proteins regulate postsynaptic function in neuron. FEBS J. 289, 2128-2144. (10.1111/febs.16285)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16285</ArticleId><ArticleId IdType="pubmed">34796656</ArticleId></ArticleIdList></Reference><Reference><Citation>Setou M, Seog DH, Tanaka Y, Kanai Y, Takei Y, Kawagishi M, Hirokawa N. 2002. Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. Nature 417, 83-87. (10.1038/nature743)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature743</ArticleId><ArticleId IdType="pubmed">11986669</ArticleId></ArticleIdList></Reference><Reference><Citation>Brachet A, Lario A, Fernandez-Rodrigo A, Heisler FF, Gutierrez Y, Lobo C, Kneussel M, Esteban JA. 2021. A kinesin 1-protrudin complex mediates AMPA receptor synaptic removal during long-term depression. Cell Rep. 36, 109499. (10.1016/j.celrep.2021.109499)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109499</ArticleId><ArticleId IdType="pubmed">34348158</ArticleId></ArticleIdList></Reference><Reference><Citation>Heisler FF, Lee HK, Gromova KV, Pechmann Y, Schurek B, Ruschkies L, Schroeder M, Schweizer M, Kneussel M. 2014. GRIP1 interlinks N-cadherin and AMPA receptors at vesicles to promote combined cargo transport into dendrites. Proc. Natl Acad. Sci. USA 111, 5030-5035. (10.1073/pnas.1304301111)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1304301111</ArticleId><ArticleId IdType="pmc">PMC3977296</ArticleId><ArticleId IdType="pubmed">24639525</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, et al. 2018. Hot-spot KIF5A mutations cause familial ALS. Brain 141, 688-697. (10.1093/brain/awx370)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. 2018. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97, 1268-1283. (10.1016/j.neuron.2018.02.027)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateno M, et al. 2004. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum. Mol. Genet. 13, 2183-2196. (10.1093/hmg/ddh246)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddh246</ArticleId><ArticleId IdType="pubmed">15294873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. 2004. Glutamate receptors: RNA editing and death of motor neurons. Nature 427, 801. (10.1038/427801a)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/427801a</ArticleId><ArticleId IdType="pubmed">14985749</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. 2019. ALS genetics, mechanisms, and therapeutics: where are we now? Front. Neurosci. 13, 1310. (10.3389/fnins.2019.01310)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllum EJ, Roberts BR, Hickey JL, Dang TN, Grubman A, Donnelly PS, Liddell JR, White AR, Crouch PJ. 2015. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism. Neurobiol. Dis. 81, 20-24. (10.1016/j.nbd.2015.02.023)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.023</ArticleId><ArticleId IdType="pubmed">25766674</ArticleId></ArticleIdList></Reference><Reference><Citation>Anggono V, et al. 2013. PICK1 interacts with PACSIN to regulate AMPA receptor internalization and cerebellar long-term depression. Proc. Natl Acad. Sci. USA 110, 13976-13981. (10.1073/pnas.1312467110)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312467110</ArticleId><ArticleId IdType="pmc">PMC3752261</ArticleId><ArticleId IdType="pubmed">23918399</ArticleId></ArticleIdList></Reference><Reference><Citation>Widagdo J, Fang H, Jang SE, Anggono V. 2016. PACSIN1 regulates the dynamics of AMPA receptor trafficking. Sci. Rep. 6, 31070. (10.1038/srep31070)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31070</ArticleId><ArticleId IdType="pmc">PMC4973260</ArticleId><ArticleId IdType="pubmed">27488904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Khorasanizadeh S, Miyoshi Y, Lazar MA, Rastinejad F. 1998. Structural elements of an orphan nuclear receptor-DNA complex. Mol. Cell 1, 849-861. (10.1016/S1097-2765(00)80084-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)80084-2</ArticleId><ArticleId IdType="pubmed">9660968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim YW, Lee M. 2020. Rapid purification method for human SFPQ by implementing zinc-induced polymerization. Protein Expr. Purif. 171, 105626. (10.1016/j.pep.2020.105626)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pep.2020.105626</ArticleId><ArticleId IdType="pubmed">32198010</ArticleId></ArticleIdList></Reference><Reference><Citation>Monk IR, et al. 2019. Zinc-binding to the cytoplasmic PAS domain regulates the essential WalK histidine kinase of Staphylococcus aureus. Nat. Commun. 10, 3067. (10.1038/s41467-019-10932-4)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10932-4</ArticleId><ArticleId IdType="pmc">PMC6624279</ArticleId><ArticleId IdType="pubmed">31296851</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragao D, et al. 2018. MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron. J. Synchrotron Radiat. 25, 885-891. (10.1107/S1600577518003120)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S1600577518003120</ArticleId><ArticleId IdType="pmc">PMC5929359</ArticleId><ArticleId IdType="pubmed">29714201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabsch W. 2010. Xds. Acta Crystallogr. D66, 125-132. (10.1107/S0907444909047337)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909047337</ArticleId><ArticleId IdType="pmc">PMC2815665</ArticleId><ArticleId IdType="pubmed">20124692</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PR, Murshudov GN. 2013. How good are my data and what is the resolution? Acta Crystallogr. D69, 1204-1214. (10.1107/S0907444913000061)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444913000061</ArticleId><ArticleId IdType="pmc">PMC3689523</ArticleId><ArticleId IdType="pubmed">23793146</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D66, 486-501. (10.1107/S0907444910007493)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalevskiy O, Nicholls RA, Long F, Carlon A, Murshudov GN. 2018. Overview of refinement procedures within REFMAC5: utilizing data from different sources. Acta Crystallogr. D74, 215-227. (10.1107/S2059798318000979)</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798318000979</ArticleId><ArticleId IdType="pmc">PMC5947762</ArticleId><ArticleId IdType="pubmed">29533229</ArticleId></ArticleIdList></Reference><Reference><Citation>Widagdo J, Chai YJ, Ridder MC, Chau YQ, Johnson RC, Sah P, Huganir RL, Anggono V. 2015. Activity-dependent ubiquitination of GluA1 and GluA2 regulates AMPA receptor intracellular sorting and degradation. Cell Rep. 10, 783-795. (10.1016/j.celrep.2015.01.015)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.01.015</ArticleId><ArticleId IdType="pmc">PMC4524782</ArticleId><ArticleId IdType="pubmed">25660027</ArticleId></ArticleIdList></Reference><Reference><Citation>Widagdo J, Udagedara S, Bhembre N, Tan JZA, Neureiter L, Huang J, Anggono V, Lee M. 2022. Familial ALS-associated SFPQ variants promote the formation of SFPQ cytoplasmic aggregates in primary neurons. Figshare. (10.6084/m9.figshare.c.6198497)</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.c.6198497</ArticleId><ArticleId IdType="pmc">PMC9516340</ArticleId><ArticleId IdType="pubmed">36168806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>